… We systematically reviewed the literature on COVID-19 in patients with multiple sclerosis (…
included any types of studies that reported characteristics of patients with MS with COVID-19. …

… MS relapses in MS patients who received COVID-19 vaccination. In this study, we aimed
to shed light on whether the innovative mRNA COVID-19 vaccination in patients with MS is …

… proportion of MS patients are not to be considered at high risk of COVID-19 mortality. Also, …
question of stopping DMT in patients with high risk of COVID-19 mortality somewhat marginal. …

… may increase the risk of COVID-19 and of a severe … of COVID-19 in patients with MS followed
at our centre, to describe their characteristics, to identify candidate risk factors for COVID-19 …

… multiple sclerosis (MS) patients to identify suspected COVID-19 cases and the factors
associated with it. They suggested that most MS patients have a mild course of CVID-19 infection. …

… describe the overall risk of coronavirus disease 2019 (COVID-19) infection, severe disease
… of COVID-19 infection in PwMS, and to provide a context using a cohort of patients with …

… and outcomes of COVID-19 in patients with multiple sclerosis (MS). This study investigated
the risks of SARS-CoV-2 infection and COVID-19-related outcomes in patients with MS, and …

The severe acute respiratory syndrome coronavirus-2 (… patients, especially those with chronic
diseases, were exposed to. We present an overview of all patients with multiple sclerosis (…

… Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter
study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this …

… and meta-analysis is to estimate the pooled prevalence of COVID-19 in patients with MS. …
of COVID-19 in patients with multiple sclerosis in Madrid Spain. Multiple Sclerosis Journal: …